9th Annual Biomarkers Congress

Cancer Biology: Wyeth BioPharma

Total Score People Score Events Score
30 27 28
Date Event Presentation Speakers
October 10, 2011 The 13th annual World Vaccine Congress Lyon is the vaccine conference addressing all major vaccine markets including Influenza, HPV, Pneumococcal and Meningococcal. Panel session | advancing Prophylactics through the clinic David McIntosh
June 27, 2011 RNAi, miRNA & siRNA Second Chair's Opening Remarks Attila A. Seyhan
Second Chair’s Closing Remarks and Close of Day One Attila A. Seyhan
RNA interference as a research and therapeutic tool…Has its time come? Attila A. Seyhan
April 27, 2010 Fragment Based Drug Discovery SPR-Based Screening of Fragment Library: Case Studies Girija Krishnamurthy
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 4 Building a Clinical Trial Unit in Academic Medical Centers Frank Fan
October 28, 2009 Immunogenicity Prediction and Reduction Impact of the Route of Administration on Immunogenicity of a Biotherapeutic: Pre-clinical Case Studies Boris Gorovits
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Translational Medicine’s Role in Target Validation and Patient Selection in Oncology Drug Development Giora Feuerstein
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Translational Medicine’s Role in Target Validation and Patient Selection in Oncology Drug Development Giora Feuerstein
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Designing, Simulating, and Executing an Adaptive Trial Vladimir Dragalin
Adaptive Designs as a Roadmap to Personalized Medicine Michael Krams
August 26, 2009 Optimizing Mammalian Cell Lines Heparin and Unfolded Protein Response Factors for Protein Expression Optimization in Mammalian Cells Xiaotian Zhong
August 3, 2009 The Next Wave of Antibody Therapeutics Targeting B-Cell Lymphomas with Inotuzumab Ozogamicin (CMC-544), an Anti-CD22 Immunoconjugate Erik R. Vandendries
June 9, 2009 Genomic Sample Prep Prolonged Storage of Plasmid DNAs under Different Conditions: Effects on Plasmid Integrity, Spectral Characteristics, and DNA Sequence Quality Jan Kieleczawa
Topic 1: Facing the Challenge of Plasmid DNA Storage Jan Kieleczawa
June 9, 2009 RNAi for Target Identification and Validation High-Throughput RNAi Genetic Screens for Drug Discovery and Development Attila A. Seyhan
June 4, 2009 Structure-Based Drug Design SPR-Based Screening of Fragment Library and Follow-up of Hits Girija Krishnamurthy
January 27, 2009 6th Annual Clinical Trial Performance Metrics Critical success factors for monitoring metrics - an example case in Japan Atsushi Kitamura
December 2, 2008 Vaccines Europe 1: Development of a bivalent Neisseria meningitidis serogroup B vaccine Lisa McNeil,
April 30, 2008 Assessment of Immunogenicity in Clinical Trials Application of Recommendations Concerning Validation of Anti-Drug Antibody Assays Boris Gorovits
Immunogenicity Testing in Non-Clinical Studies Bonita Rup
March 25, 2008 Mastering Medicinal Chemistry SAR in the Area of Antibody-Targeted Chemotherapy: Philip R Hamann
December 4, 2007 7th World Drug Discovery & Development Summit 2007 KEYNOTE: ACADEMIC AND INDUSTRY COLLABORATION - THE FUTURE FOR DISCOVERY AND DEVELOPMENT Orest Hurko
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CLINICAL DEVELOPMENT AND OPERATIONS (09:10-14:45) Dianne C. Kikta
CLINICAL DEVELOPMENT AND OPERATIONS: INTERACTIVE PANEL:Outsourcing Globally and Executing International Trials in India (14:00-14:45) Dianne C. Kikta
CLINICAL DEVELOPMENT AND OPERATIONS: An Innovative Approach to Establishing a Clinical Research Presence in India: The Wyeth Experience (09:50-10:30) Dianne C. Kikta
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Tatjana Matejic
Assessing Structure/Function Relationships :Developing Functional Bioassays to Monitor Quality of Protein Therapeutics (08:45-09:15) Tatjana Matejic
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 13: (Part One) Development of Novel Drug Delivery Systems (Part Two) Combinatorial Chemistry & High Throughput Screening (09:00-12:00) Xiaoke Yang
Session 13: (Part One): Binding Characterization of the IL-13 Signaling Complex and Development of a Ternary TR-FRET Assay (10:20-10:40) Xiaoke Yang
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) TARGETING NEUROPSYCHIATRIC DISORDERS (15:45-18:20) John Dunlop
TARGETING NEUROPSYCHIATRIC DISORDERS: Exploring Positive Allosteric Modulators of the Alpha7 Nicotinic Receptor (15:45-16:15) John Dunlop
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) DISCOVERY CHEMISTRY (08:35-12:55) Matthew R. Yudt
DISCOVERY CHEMISTRY: Discovery of Progesterone Receptor Modulators with a Unique Mechanism of Action (10:55-11:25) Matthew R. Yudt
October 16, 2007 Inaugural Kinbase Inhibitors: Moving Forward into Clinical Studies Oct (16-17) New Therapeutics Scopes (10:35-12:40) Jean-Baptiste Telliez
New Therapeutics Scopes: The MK2/MK3 Pathway in Inflammation and Beyond (10:40-11:10) Jean-Baptiste Telliez
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies (08:30-10:40) Brian Bates
In vitro RNAi Screening Strategies: Probing Mammalian Neuritogenesis through siRNA Screening (09:40-10:10) Brian Bates
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Alex Valentin
Studying Fracture Healing - The Use of Bioimaging for Recombinant Human Bone Morphogenetic Protein-2 (Rhbmp-2) Studies (08:05-08:35) Alex Valentin
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Case Studies (15:30-17:30) Fred Immermann
Case Studies: From GeneChip to Taqman Low Density Array ­ Comparing Microarray and PCR-based Gene Expression Measurements (15:30-16:00) Fred Immermann
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: The Role of Pharmacogenomics in Discovery Translational Medicine: From Target Validation to Patient Selection (08:35-09:05) Giora Feuerstein
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Giora Feuerstein
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.